MA53897A - Nouveau procédé de synthèse de dérivés de pipérazinyl-éthoxy-bromophényle et leur application dans la production de composés les contenant - Google Patents

Nouveau procédé de synthèse de dérivés de pipérazinyl-éthoxy-bromophényle et leur application dans la production de composés les contenant

Info

Publication number
MA53897A
MA53897A MA053897A MA53897A MA53897A MA 53897 A MA53897 A MA 53897A MA 053897 A MA053897 A MA 053897A MA 53897 A MA53897 A MA 53897A MA 53897 A MA53897 A MA 53897A
Authority
MA
Morocco
Prior art keywords
piperazinyl
ethoxy
synthesis
production
application
Prior art date
Application number
MA053897A
Other languages
English (en)
Inventor
Louis-Philippe Beauregard
Martial Bertrand
Pascall Giguere
Christophe Hardouin
Bruno Schiavi
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MA53897A publication Critical patent/MA53897A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/025Boronic and borinic acid compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA053897A 2018-10-15 2019-10-14 Nouveau procédé de synthèse de dérivés de pipérazinyl-éthoxy-bromophényle et leur application dans la production de composés les contenant MA53897A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18306354 2018-10-15

Publications (1)

Publication Number Publication Date
MA53897A true MA53897A (fr) 2022-01-19

Family

ID=63965576

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053897A MA53897A (fr) 2018-10-15 2019-10-14 Nouveau procédé de synthèse de dérivés de pipérazinyl-éthoxy-bromophényle et leur application dans la production de composés les contenant

Country Status (14)

Country Link
US (1) US11512062B2 (fr)
EP (1) EP3867233A1 (fr)
JP (1) JP7448532B2 (fr)
KR (1) KR20210076094A (fr)
CN (1) CN112930340A (fr)
AR (1) AR116635A1 (fr)
BR (1) BR112021006467A2 (fr)
CA (1) CA3115608A1 (fr)
EA (1) EA202190989A1 (fr)
IL (1) IL282094A (fr)
MA (1) MA53897A (fr)
MX (1) MX2021004288A (fr)
NZ (1) NZ774813A (fr)
WO (1) WO2020078875A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202315637A (zh) 2021-06-11 2023-04-16 美商基利科學股份有限公司 Mcl-1抑制劑與抗癌劑之組合
TW202317200A (zh) 2021-06-11 2023-05-01 美商基利科學股份有限公司 Mcl-1抑制劑與抗體藥物接合物之組合

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401824A (en) * 1982-03-08 1983-08-30 The Upjohn Company Benzopyran compounds, derivatives of prostaglandins
US6867203B2 (en) * 1998-12-29 2005-03-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
GB0500029D0 (en) * 2005-01-04 2005-02-09 Univ Belfast Basic ionic liquids
US7759337B2 (en) * 2005-03-03 2010-07-20 Amgen Inc. Phthalazine compounds and methods of use
WO2007047146A2 (fr) * 2005-10-11 2007-04-26 Intermune, Inc. Inhibiteurs de réplication virale
TW201107302A (en) * 2009-06-26 2011-03-01 Glaxo Group Ltd Compounds
BR112012011310A2 (pt) * 2009-11-11 2016-04-12 Dainippon Sumitomo Pharma Co compostos derivados de 8-azabiciclo[3.2.1]octano-8-carboxamida, seu medicamento, seu agente terapêutico e seu uso
EP3444252B1 (fr) * 2011-06-17 2019-08-14 NantEnergy, Inc. Cellule electrochimique comprenant un additif hetero-ionique
TWI464242B (zh) * 2012-10-26 2014-12-11 Ind Tech Res Inst 負介電異方性液晶化合物、液晶顯示器、與光電裝置
KR102006994B1 (ko) * 2013-03-28 2019-08-02 주식회사 삼양사 신규 페난트렌 화합물, 이의 제조방법 및 이를 이용한 유기전자소자
WO2015024203A1 (fr) * 2013-08-20 2015-02-26 Leo Pharma A/S Nouveaux composés ii antagonistes du récepteur de la neurokinine 1
FR3015483B1 (fr) * 2013-12-23 2016-01-01 Servier Lab Nouveaux derives de thienopyrimidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2946471C (fr) * 2014-04-25 2018-08-07 Pfizer Inc. Composes heteroaromatiques bicyclique fusionnes et leur utilisation comme ligands de dopamine d1
WO2015187089A1 (fr) * 2014-06-04 2015-12-10 Thomas Helledays Stiftelse För Medicinsk Forskning Inhibiteurs de mth1 destinés au traitement des états inflammatoires et auto-immuns
FR3037959B1 (fr) 2015-06-23 2017-08-04 Servier Lab Nouveaux derives bicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037958B1 (fr) 2015-06-23 2019-01-25 Les Laboratoires Servier Nouveaux derives d'hydroxy-acide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3037956B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3046792B1 (fr) 2016-01-19 2018-02-02 Les Laboratoires Servier Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US10106553B2 (en) * 2016-04-11 2018-10-23 Janssen Pharmaceutica Nv Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes
KR101891263B1 (ko) * 2016-07-20 2018-08-23 주식회사 엘지화학 신규한 헤테로고리 화합물 및 이를 포함하는 유기발광 소자
LT3532067T (lt) * 2016-10-28 2022-08-25 Les Laboratoires Servier Liposominė vaisto forma, skirta naudoti gydant vėžį
CN107573360B (zh) * 2017-10-27 2019-08-09 都创(上海)医药科技有限公司 一种多靶点小分子化合物s63845的制备方法

Also Published As

Publication number Publication date
AU2019362310A1 (en) 2021-05-13
US20210380549A1 (en) 2021-12-09
EP3867233A1 (fr) 2021-08-25
US11512062B2 (en) 2022-11-29
WO2020078875A1 (fr) 2020-04-23
CA3115608A1 (fr) 2020-04-23
EA202190989A1 (ru) 2021-07-05
KR20210076094A (ko) 2021-06-23
CN112930340A (zh) 2021-06-08
NZ774813A (en) 2024-07-26
BR112021006467A2 (pt) 2021-07-13
AR116635A1 (es) 2021-05-26
MX2021004288A (es) 2021-05-31
JP7448532B2 (ja) 2024-03-12
JP2022512694A (ja) 2022-02-07
IL282094A (en) 2021-05-31
TW202033506A (zh) 2020-09-16

Similar Documents

Publication Publication Date Title
MA42231A (fr) Nouveaux dérivés d'hydroxyacide, leur procédé de préparation, et compositions pharmaceutiques les contenant
DK3728215T3 (da) One-pot-proces til fremstilling af racemisk nikotin ved omsætning af ethylnicotinat med N-vinylpyrrolidon i nærvær af natriumethanolat eller kaliumethanolat eller blandinger deraf
MA52665A (fr) Procédé d'amélioration de l'expression de l'hémoglobine foetale
MA46744A (fr) Composés mono et spirocycliques contenant du cyclobutane et de l'azétidine en tant qu'inhibiteurs de l'intégrine alpha v
MA50855A (fr) Procédé de génération de compositions thérapeutiques de cellules modifiées
MA51988A (fr) Procédé pour la préparation de composés utiles à traiter l'amyotrophie spinale
MA53897A (fr) Nouveau procédé de synthèse de dérivés de pipérazinyl-éthoxy-bromophényle et leur application dans la production de composés les contenant
MA51114A (fr) Procédé de production d'une compositions de lymphocytes t modifiés
FR3037957B1 (fr) Nouveaux derives d'hydroxyester, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MA41861A (fr) Composition d'élastomère thermoplastique et son procédé de production
MA47000A (fr) Procédé et composition pour l'obtention d'un produit de farine amélioré
MA48723A (fr) Procédé de production d'anticorps multispécifiques
MA42232B1 (fr) Nouveaux dérivés d'acide aminé, leur procédé de préparation et compositions pharmaceutiques les contenant
CO6531444A2 (es) Métodos sintéticos para compuestos espiro-oxoindol
MA38803A1 (fr) Nouveaux dérivés d'indolizine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
IL275321A (en) Treatment of diseases associated with the expression of DUX4
MA55917A (fr) Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie
MA56056A (fr) Nouveau procédé efficace de synthèse de 2-amino-5-chloro-n-,3-diméthylbenzamide
MA49700A (fr) Procédé amélioré pour la préparation de dérivés d'aminopyrimidine
MA53728A (fr) Nouveau procédé enzymatique pour la production de produits de houblon modifiés
BR112016013618A8 (pt) derivados de maleimida como moduladores de série de reação de wnt, seus usos, composição farmacêutica e processo para a preparação dos mesmos
MA53900A (fr) Nouveaux dérivés d'amino-pyrimidonyl-pipéridinyl, leur procédé de préparation et compositions pharmaceutiques les contenant
CY1122172T1 (el) Τροποποιητες θειαζολης των a3 υποδοχεων αδενοσινης
MA51870A (fr) Procédé pour la préparation de composés coupleurs de médicaments
MA47409A (fr) Nouveau procédé de synthèse de 1-aryl-1-trifluorométhylcyclopropanes